Published in: Clinical and experimental hypertension (New York, N.Y. : 1993) (2024)
This study revealed that emodin targeted the PI3K/AKT/mTOR pathway to inhibit the development of myocardial fibrosis and may be an antifibrotic agent for the treatment of cardiac fibrosis.